| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 994 | 2018 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 417 | 2018 |
| Dapagliflozin in myocardial infarction without diabetes or heart failure S James, D Erlinge, RF Storey, DK McGuire, M de Belder, N Eriksson, ... NEJM evidence 3 (2), EVIDoa2300286, 2024 | 115 | 2024 |
| Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial A Jabbar, L Ingoe, S Junejo, P Carey, C Addison, H Thomas, JD Parikh, ... Jama 324 (3), 249-258, 2020 | 62 | 2020 |
| Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials EP Navarese, D Austin, PA Gurbel, F Andreotti, U Tantry, S James, ... Clinical Research in Cardiology 102, 279-287, 2013 | 43 | 2013 |
| A critical overview on ticagrelor in acute coronary syndromes EP Navarese, A Buffon, M Kozinski, K Obonska, M Rychter, V Kunadian, ... QJM: An International Journal of Medicine 106 (2), 105-115, 2013 | 40 | 2013 |
| Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study A Jabbar, L Ingoe, H Thomas, P Carey, S Junejo, C Addison, J Vernazza, ... Journal of Endocrinological Investigation 44, 1209-1218, 2021 | 30 | 2021 |
| Patient characteristics associated with self-presentation, treatment delay and survival following primary percutaneous coronary intervention D Austin, AT Yan, JC Spratt, V Kunadian, RJ Edwards, M Egred, ... European Heart Journal: Acute Cardiovascular Care 3 (3), 214-222, 2014 | 26 | 2014 |
| Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score–matched outcome study D Austin, KG Oldroyd, A McConnachie, R Slack, H Eteiba, AD Flapan, ... Circulation: Cardiovascular Interventions 1 (1), 45-52, 2008 | 24 | 2008 |
| IVUS and OCT guided primary percutaneous coronary intervention for spontaneous coronary artery dissection with bioresorbable vascular scaffolds MM Mahmood, D Austin Cardiovascular Revascularization Medicine 18 (1), 53-57, 2017 | 22 | 2017 |
| Telomerase activation to reverse immunosenescence in elderly patients with acute coronary syndrome: protocol for a randomized pilot trial R Maier, B Bawamia, K Bennaceur, S Dunn, L Marsay, R Amoah, A Kasim, ... JMIR Research Protocols 9 (9), e19456, 2020 | 20 | 2020 |
| Drug-eluting stents: a study of international practice D Austin, KG Oldroyd, DR Holmes Jr, CS Rihal, PD Galbraith, WA Ghali, ... American heart journal 158 (4), 576-584, 2009 | 20 | 2009 |
| Invasive treatment strategy for older patients with myocardial infarction V Kunadian, H Mossop, C Shields, M Bardgett, P Watts, MD Teare, ... New England Journal of Medicine 391 (18), 1673-1684, 2024 | 16 | 2024 |
| Radial versus femoral access for rotational atherectomy: a UK observational study of 8622 patients J Watt, D Austin, D Mackay, J Nolan, KG Oldroyd Circulation: Cardiovascular Interventions 10 (12), e005311, 2017 | 16 | 2017 |
| Sample timing, diagnosis of subclinical thyroid dysfunction and mortality in acute myocardial infarction: ThyrAMI1 study S Razvi, O Leng, A Jabbar, A Bano, L Ingoe, C Addison, H Thomas, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), e1299-e1306, 2020 | 15 | 2020 |
| High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study D Austin, DF Mackay, R Morley, J Christie, B Hennigan, MA de Belder, ... EuroIntervention 10 (10), 1187-1194, 2015 | 15 | 2015 |
| Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in Scotland D Austin, KG Oldroyd, A McConnachie, R Slack, H Eteiba, AD Flapan, ... Journal of public health 30 (2), 186-193, 2008 | 15 | 2008 |
| Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease SX Loh, Y Ekinci, L Spray, V Jeyalan, T Olin, G Richardson, D Austin, ... Journal of Clinical Medicine 12 (14), 4821, 2023 | 14 | 2023 |
| Drug-eluting stents: do the risks really outweigh the benefits? D Austin, JP Pell, KG Oldroyd Heart 94 (2), 127-128, 2008 | 11 | 2008 |
| Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction B Bawamia, L Spray, VK Wangsaputra, K Bennaceur, S Vahabi, K Stellos, ... GeroScience 45 (4), 2689-2705, 2023 | 10 | 2023 |
